Polarized Xenon Production Multi-liter Accumulation

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R41HL078285-01
Agency Tracking Number: HL078285
Amount: $102,965.00
Phase: Phase I
Program: STTR
Awards Year: 2004
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
XEMED, LLC
XEMED, LLC, 9 LIBRARY WAY, DURHAM, NH, 03824
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 WILLIAM HERSMAN
 (603) 862-3512
 hersman@unh.edu
Business Contact
 F HERSMAN
Phone: (603) 862-3512
Email: HERSMAN@UNH.EDU
Research Institution
 UNIVERSITY OF NEW HAMPSHIRE
 OFFICE OF SPONSORED RESEARCH
Durham, NH, 03824
 Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): Since its first demonstration as an imaging agent in MRI nearly a decade ago, the promise of hyperpolarized xenon has captured the attention of the research community. It can be introduced into a subject non-invasively by breathing, and has a well-understood short-term biological effect. Relative to hyperpolarized helium, its advantages include its natural abundance and low cost. Both hyperpolarized xenon and helium have demonstrated utility in lung imaging, and quantifying lung disease. In contrast to helium, however, hyperpolarized xenon has a high solubility in fluids and tissues and a characteristic chemical shift, revealing its microscopic environment in dissolved-phase imaging. Consequently, the time dependence of its transport and absorption offer prospects for functional imaging of perfusion. Using NIH R21 and R15 funds, the UNH group demonstrated a new type of xenon polarizer that flows the gas mixture at relatively high velocity and low pressure along a direction opposite to the laser beam. This polarizer demonstrated polarization of over 20% for a production rate of over four liters per hour. The figure-of-merit (polarization times production rate) of this polarizer presently exceeds all other polarizer technologies by an order of magnitude. The technology routinely used to accumulate hyperpolarized xenon, freezing in a liquid-nitrogen bath, is not well suited to accumulating multi-liter quantities. We request STTR funding to develop and test a novel, scalable approach to accumulating unlimited quantities of hyperpolarized xenon. This new method of accumulating the hyperpolarized gas will extend the capacity of our world-leading hyperpolarized xenon production apparatus. This development helps to convert this laboratory installation to a practical hospital based device. Hyperpolarized gas has already demonstrated utility in diagnosing and quantifying lung disease. We present technological, physiological, and economic arguments that hyperpolarized xenon can and perhaps will surpass gadolinium as the contrast agent of choice in a broad spectrum of diagnostic imaging protocols.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government